Stem Cells for Cellular Therapy 2010 Market Report
Publisher:
Select Biosciences
Published:
January 2010
Pages: 113
This is the latest and most up-to-date Market Report from
Select Biosciences addressing the cellular therapy space. Select Biosciences’
industry coverage of the stem cells space is broad and comprehensive—each
segment of the space is therefore analyzed and presented in detail in a market
report. This market report is focused on presenting the market characteristics
of stem cells as they are currently impacting research in the cellular therapy
space. Furthermore, this report also addresses an important market, namely that
of Umbilical Cord Blood Banking.
- Qualitative and Quantitative Trends in the Stem Cells Space: Quantitative
Market Forecast (Market Size) by Product Class in the Stem Cells Space and
Corresponding Growth Rates
- Quantitative Market Forecast (Market Size) by Worldwide Region for Stem
Cells Activities and Corresponding Growth Rates
- Primary Market Survey Data Derived from a Worldwide Pool of Industry
Participants Representing a Broad Cross Section of the Stem Cells Research Field
- Cord Blood Banking Marketplace: Qualitative Market Trends, Quantitative
Market Metrics including Size of Public and Private Cord Blood Banks, Breakout
by Country, Growth Rates
- Utilization of Cord Blood in Hematopoietic Transplantation: Quantitative
Breakout by Patient Population, Transplant Type, Disease Demographics
- Mesenchymal Stem Cells (MSCs) for Cellular Therapy: Detailed Presentation of
the MSC Space From a Technical Perspective: Phenotype, Characteristics,
Mechanisms of Action
An important feature of this market report are the extensive primary
market analysis data including primary market survey data from worldwide
respondent pools of stem cell research. - Utilization of Various Stem Cell Types in Different Activities:
iPSCs, ESCs, MSCs, HSCs, and NSCs.
- Quantitative Market Penetrance (into the Research Community) of
Various Vendors Offering Products/Services to the Stem Cells Researchers
Worldwide
- Markers for Characterizing iPSCs, ESCs, MSCs, HSCs, and
NSCs.
- Cellular Therapeutics for Cardiovascular Diseases and CNS Diseases:
Market Characteristics.
This data-driven characterization of the stem cells landscape as it relates
to cellular therapy is a hands-on document that can be used for competitive
benchmarking, business planning, and strategy development—all the data that have
been collected in this industry analysis are presented and they form the basis
for the conclusions drawn throughout the market report presented in a format
enabling “drag-and-drop” into business presentations/business plans.
Extensive Worldwide
Technical and Market Analyses Presented in this Report:
- The Waves of Cellular Therapy
- Worldwide Total Quantitative Market Opportunity and Growth in the Stem Cells
Space
- Stem Cells Market Forecast by Technology/Product Type
- Stem Cells Market Forecast by Global Region
- US Patient Populations Amenable to Cellular Therapies
- Cellular Therapy Quantitative Market Opportunity
- Business Models in the Cellular Therapy Space
- Primary Research Applications of Stem Cells
- Quantitative Market Penetrance of Vendors Offering Products for the Stem
Cells Marketplace
- Drug Discovery, Toxicity Screening using Stem Cells: Market Characteristics
- Penetrance of Different Cell Types for Cellular Therapy Applications
- Differentiation of iPSCs, hESCs, MSCs, HSCs, NSCs into Various Lineages
- Markers for Characterizing hESCs, iPSCs, MSCs, HSCs, NSCs
- Breakout of Therapeutics Areas in Cellular Therapy: Cardiovascular Diseases,
CNS Diseases
- Cellular Therapeutics Timeline: Cardiovascular Diseases, CNS Diseases
- Cellular Therapeutic Delivery Routes: Cardiovascular Diseases, CNS Diseases
- Cell Types for Cellular Therapy of Cardiovascular Disease, CNS Disease
- Proposed Mechanism of Action of Cellular Therapeutics
- Cord Blood Banking: Market Characteristics
- Cord Blood Units Stored in Public Cord Blood Banks: Updated as of December
2009
- Various Public Cord Blood Registries Worldwide: Breakout of Stored Cord
Blood Units
- Cord Blood Transplants versus Bone Marrow Transplants
- Quantitative Transplantation Trends for Adult Recipients versus Pediatric
Recipients
- Current Use and Outcome of Hematopoietic Stem Cell Transplantation
- Mesenchymal Stem Cells [MSCs] for Cellular Therapy
- More details of the scope of coverage of this industry report are found in
the Table of Contents (TOC) for the report—see below for link to downloadable
PDF of the TOC
This data-driven characterization of the microRNA research
landscape is a hands-on document that can be used for competitive benchmarking,
business planning, and strategy development—all the data that have been
collected in this industry analysis are presented and they form the basis for
the conclusions drawn throughout the market report presented in a format
enabling “drag-and-drop” into business presentations/business plans.
For enquiries about this market report, please contact Jeff Fan at
j.fan@selectbio.com
|
